MIB acquires Clareto in strategic deal with Munich Re Life US to revolutionize life insurance underwriting through electronic medical data

In a strategic move that signals accelerating digital transformation within the life insurance sector, MIB Group Holdings, Inc. has acquired Clareto, a major provider of electronic health record (EHR) access for insurers, from Munich Re Life US. The acquisition forms part of a deeper partnership between MIB and Munich Re Life US, aimed at streamlining life insurance underwriting by advancing access to electronic medical data and embedding advanced data analytics into the process.

The collaboration is designed to consolidate MIB’s Medical Data Solutions platform with Clareto’s robust EHR retrieval network, effectively creating what the companies describe as a market-leading offering in a fragmented industry landscape. The partnership will be deployed under the MIB EHR platform, with both parties contributing their data ecosystems and analytics capabilities to enhance automated risk assessment in life insurance.

What Does the MIB–Clareto Acquisition Mean for Electronic Health Record Access?

The acquisition of Clareto by MIB marks a significant milestone in the push toward automated, data-driven underwriting workflows. As part of the transaction, MIB not only inherits Clareto’s broad EHR access network but also positions itself to offer reflexive data retrieval services. This includes automated transitions to traditional attending physician statements (APS) when EHRs are unavailable—a common challenge in digitized underwriting.

The collaboration deepens with the integration of services from RiskRighter, MIB’s own data summarization business, alongside Munich Re’s proprietary alitheia platform, which enables real-time risk scoring and automated underwriting decisions. Together, these elements expand access to medical records while enabling flexible summarization options that cater to different levels of underwriting complexity.

With the combined solution, life insurers are expected to benefit from reduced manual intervention, faster decision turnaround times, and more comprehensive health data, which will support more precise risk stratification across applicant pools.

Why Is the Life Insurance Industry Shifting to Electronic Medical Data?

The shift toward electronic medical data in life insurance underwriting has been steadily progressing over the last decade, largely driven by the need for efficiency and accuracy. Traditional underwriting often relies on time-consuming manual record retrieval from healthcare providers. In contrast, platforms that can access electronic health records offer a faster, more scalable method for assessing medical risk.

This transformation has been bolstered by increasing digitization across the healthcare system and regulatory frameworks such as the 21st Century Cures Act in the United States, which promotes patient access to electronic health data. For life insurers, the use of electronic medical data has not only become a competitive necessity but also a means to improve customer satisfaction through quicker policy issuance.

The MIB-Clareto-Munich Re integration responds directly to these industry-wide challenges and aspirations. The alignment of complementary capabilities—from data collection to advanced analytics—is set to offer a seamless experience for insurers seeking comprehensive digital underwriting tools.

How Will Munich Re Life US Contribute to This Partnership?

As a global leader in reinsurance and digital innovation in insurance risk assessment, Munich Re Life US brings deep technical expertise and thought leadership to the partnership. The company has long advocated for smarter use of digital health data and has developed tools such as alitheia to power faster underwriting decisions. Through its prior relationship with Clareto, Munich Re has gained firsthand knowledge of how EHRs can be operationalized at scale.

Munich Re Life US will continue to be involved by co-developing analytics frameworks with MIB, aimed at enhancing automation and expanding innovation in the medical data segment. The partnership also includes plans to publish insights and case studies to advance industry understanding of the evolving digital health data landscape.

According to company representatives, the collaboration reflects a broader vision to enhance the insurance value chain—from quote to policy issuance—by embedding data intelligence into each stage.

What Does This Mean for MIB’s Position in the Market?

MIB has traditionally served as the insurance industry’s trusted provider of data-driven solutions. The acquisition of Clareto significantly expands its value proposition, especially at a time when insurers are actively seeking platforms that can aggregate, analyze, and interpret health data with high fidelity and speed.

Brian Winikoff, President and CEO of MIB, indicated that this move is part of a broader diversification strategy to meet emerging market needs. He noted that the process of securing high-quality data for underwriting continues to be fragmented and inefficient—an issue that MIB aims to solve through this integration.

By combining Clareto’s network with MIB’s existing infrastructure and Munich Re’s analytics layer, the company is set to become a “one-stop shop” for life insurers needing comprehensive digital health data solutions.

What Is the Market Outlook Following the Deal?

Although MIB and Munich Re Life US are privately held, the broader impact of their collaboration could have indirect implications for publicly traded life insurance companies. Firms investing in digital underwriting platforms may benefit from improved margins and operational efficiency, especially as consumer expectations shift toward faster policy issuance.

Investor sentiment around health-tech integrations in insurance has remained positive, with many viewing digital underwriting tools as both a cost-saving mechanism and a growth enabler. As insurers increasingly adopt EHR-enabled solutions, vendors like MIB and its subsidiaries may play a central role in shaping industry standards.

In the longer term, this partnership may signal a shift in the competitive dynamics of life insurance underwriting—where access to comprehensive, real-time health data and the ability to analyze it meaningfully will differentiate leaders from laggards.

What’s Next for the Life Insurance Underwriting Ecosystem?

The MIB-Clareto acquisition and partnership with Munich Re Life US underscores a critical evolution in underwriting: a pivot from fragmented, paper-based systems to fully integrated digital ecosystems. This move is not just about accessing more data—it’s about accessing better data, faster, and using it to drive decisions with greater precision and consistency.

As underwriting continues to evolve in an era defined by automation and data intelligence, industry leaders are likely to seek partnerships and acquisitions that enhance their access to actionable insights. The integration of Clareto’s EHR capabilities into MIB’s platform, enhanced by Munich Re’s analytics firepower, is likely to be viewed as a model for how insurers can future-proof their underwriting processes.

Ultimately, this strategic alignment is expected to benefit insurers, applicants, and the broader healthcare ecosystem—creating a smoother, faster, and more transparent pathway to coverage.